MARTINGALE ASSET MANAGEMENT L P

Position in LGND — Ligand Pharmaceuticals Inc

CIK 936944 BOSTON, MA

Position in LGND

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$5,551,172

+$2,004,989 QoQ

Shares Held

17,562

-1.1% QoQ

Ownership

0.088%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#105

of 411 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 64% Shared 0% None 36%

Healthcare · as of Jun 30, 2026

MARTINGALE ASSET MANAGEMENT L P holds $144,833,314 across 62 Biotechnology names. LGND ranks #5 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	42,729	$21,224,776
2	INCY	Incyte Corp	168,818	$19,137,208
3	JAZZ	Jazz Pharmaceuticals plc	59,492	$14,335,787
4	REGN	Regeneron Pharmaceuticals, Inc.	18,953	$11,817,953
5	LGND	Ligand Pharmaceuticals Inc This page	17,562	$5,551,172
6	ACAD	Acadia Pharmaceuticals Inc	167,893	$4,247,692
7	ALNY	Alnylam Pharmaceuticals, Inc.	13,634	$4,104,243
8	INVA	Innoviva, Inc.	165,115	$3,749,761

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,551,172	17,562	-1.1%	Shares	Sole	2026-08-13
2026-03-31	$3,546,183	17,762	+15.9%	Shares	Sole	2026-05-13
2025-12-31	$2,896,929	15,322	-17.1%	Shares	Sole	2026-02-13
2025-09-30	$3,272,129	18,472	-8.3%	Shares	Sole	2025-11-13
2025-06-30	$2,290,992	20,153	+5.8%	Shares	Sole	2025-08-11
2025-03-31	$2,003,126	19,052	+5.3%	Shares	Sole	2025-05-14
2024-12-31	$1,938,557	18,092	+1.5%	Shares	Sole	2025-02-13
2024-09-30	$1,783,803	17,822	-11.0%	Shares	Sole	2024-11-14
2024-06-30	$1,687,052	20,022	-37.0%	Shares	Sole	2024-08-12
2024-03-31	$2,323,044	31,779	-0.6%	Shares	Sole	2024-05-14
2023-12-31	$2,282,511	31,959	-0.5%	Shares	Sole	2024-02-12
2023-09-30	$1,924,869	32,124	+13.6%	Shares	Sole	2023-11-14
2023-06-30	$2,038,339	28,271	+137.8%	Shares	Sole	2023-08-11
2023-03-31	$874,701	11,891	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.